Cargando…

Cancer stem cell markers ALDH1 and CD44+/CD24– phenotype and their prognosis impact in invasive ductal carcinoma

Detalles Bibliográficos
Autores principales:	Rabinovich, Iris, Sebastião, Ana Paula Martins, Lima, Rubens Silveira, de Andrade Urban, Cícero, Jr., Eduardo Schunemann, Anselmi, Karina Furlan, Elifio-Esposito, Selene, de Noronha, Lucia, Moreno-Amaral, Andréa Novais
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240790/ https://www.ncbi.nlm.nih.gov/pubmed/30362671 http://dx.doi.org/10.4081/ejh.2018.2943

Ejemplares similares

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
por: Lin, Li, et al.
Publicado: (2013)

Exposed Implant after Immediate Breast Reconstruction – Presentation and Analysis of a Clinical Management Protocol
por: Hassan, Rafael Amin Menezes, et al.
Publicado: (2021)

Prospective study: Impact of breast magnetic resonance imaging on oncoplastic surgery and on indications of mastectomy in patients who were previously candidates to breast conserving surgery
por: Anselmi, Karina Furlan, et al.
Publicado: (2023)

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2017)

Differential expression of HIF-1α in CD44(+)CD24(-/low )breast ductal carcinomas
por: Oliveira-Costa, João Paulo, et al.
Publicado: (2011)

Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2018)

Intraoperative Assessment of Endogenous Microbiota in the Breast
por: Stachon, Henrique, et al.
Publicado: (2021)

Oncological safety of nipple-sparing mastectomy after neoadjuvant chemotherapy: a systematic review
por: NISSEN, LEONARDO, et al.
Publicado: (2023)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
por: Han, Zhengquan, et al.
Publicado: (2015)

STAT3 as a potential therapeutic target in ALDH(+) and CD44(+)/CD24(+) stem cell-like pancreatic cancer cells
por: Lin, Li, et al.
Publicado: (2016)

Reliability of CD44, CD24, and ALDH1A1 immunohistochemical staining: Pathologist assessment compared to quantitative image analysis
por: Yaghjyan, Lusine, et al.
Publicado: (2022)

ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas
por: Adams, April, et al.
Publicado: (2015)

The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer
por: Huang, Hsin-Hui, et al.
Publicado: (2018)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010)

Expression of Androgen Receptor and Cancer Stem Cell Markers (CD44(+)/CD24(−) and ALDH1(+)): Prognostic Implications in Invasive Breast Cancer()()
por: Riaz, Nazia, et al.
Publicado: (2018)

Prognostic Value of Cancer Stem Cell Markers CD44 and ALDH1/2 in Gastric Cancer Cases
por: Senel, Fatma, et al.
Publicado: (2017)

Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells
por: Liu, Jing, et al.
Publicado: (2013)

Association between ALDH1+/CD133+ stem-like cells and tumor angiogenesis in invasive ductal breast carcinoma
por: LV, XINQUAN, et al.
Publicado: (2016)

Knockdown of ALDH1A3 reduces breast cancer stem cell marker CD44 via the miR-7-TGFBR2-Smad3-CD44 regulatory axis
por: Pan, Meng, et al.
Publicado: (2021)

Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases
por: Horimoto, Yoshiya, et al.
Publicado: (2016)

Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis
por: Durko, L., et al.
Publicado: (2017)

Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”
por: Durko, L., et al.
Publicado: (2017)

CD44(+)/CD24(-) phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma
por: Lin, Yan, et al.
Publicado: (2012)

CD44/CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasms
por: Soave, Danilo Figueiredo, et al.
Publicado: (2013)

The liberation of CD44
por: Cichy, Joanna, et al.
Publicado: (2003)

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Publicado: (1996)

Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity
por: Cortes-Dericks, Lourdes, et al.
Publicado: (2014)

Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC
por: Jakob, Mark, et al.
Publicado: (2020)

ALDH1+ stem cells demonstrate more stem cell-like characteristics than CD44(+)/CD24(–/low) stem cells in different molecular subtypes of breast cancer
por: Chen, Jie, et al.
Publicado: (2020)

Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells
por: Montero-Montero, Lucía, et al.
Publicado: (2020)

CD44 Modulates Cell Migration and Invasion in Ewing Sarcoma Cells
por: Fernández-Tabanera, Enrique, et al.
Publicado: (2023)

Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma
por: Hou, Ya-Chin, et al.
Publicado: (2014)

Neutrophils activated by BJcuL, a C-type lectin isolated from Bothrops jararacussu venom, decrease the invasion potential of neuroblastoma SK-N-SH cells in vitro
por: Carneiro-Goetten, Jessica Ohana Lemes, et al.
Publicado: (2020)

Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients
por: Strati, Areti, et al.
Publicado: (2019)

The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients
por: Izycka, Natalia, et al.
Publicado: (2023)

Another Notch in CD44
por: Dove, Alan W.
Publicado: (2001)

CD44 in rheumatoid arthritis
por: Naor, David, et al.
Publicado: (2003)

Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway
por: Okamoto, Isamu, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_pvv6l25h3glunc5602c7lqpq60